Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dexmedetomidine on Postoperative Delirium in Patients Undergoing Brain Tumor Resections: a Randomized Controlled Study

NCT04674241 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT04674241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dexmedetomidine on Postoperative Delirium in Patients Undergoing Brain Tumor Resections: a Randomized Controlled Study
Lead sponsor
Beijing Tiantan Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 18, 2021
Completion date
January 28, 2022
Enrollment
260 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, postoperative delirium